Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 233-986-8 | CAS number: 10482-56-1
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
![](https://echa.europa.eu./o/diss-blank-theme/images/factsheets/A-REACH/factsheet/print_toxicological-information.png)
Endpoint summary
Administrative data
Description of key information
In vivo skin sensitisation. Weight of evidence. Read-across approach: Popliteal lymph node assay (PLNA). Based on the read-across approach from the analogue alpha terpineol, laevo alpha terpineol can be considered as non sensitiser.
In vivo skin sensitisation. Weight of evidence. Read-across approach: Modified FCA-method (Freund’s complete adjuvant) similar to OECD 406 Guideline. Based on the read-across approach from the analogue alpha terpineol, laevo alpha terpineol can be considered as non sensitiser.
Key value for chemical safety assessment
Skin sensitisation
Link to relevant study records
- Endpoint:
- skin sensitisation: in vivo (non-LLNA)
- Type of information:
- experimental study
- Adequacy of study:
- weight of evidence
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- study well documented, meets generally accepted scientific principles, acceptable for assessment
- Qualifier:
- no guideline followed
- Principles of method if other than guideline:
- - Principle of test:
Rat popliteal lymph node assay (PLNA). Although the predictive value of PLNA was initially focused on auto-immune-like reactions, more recently it has been regarded as a screening test useful for detecting a broader class of sensitizing or immuno-stimulating chemicals (Pieters and Albers, 1999; Ravel and Descotes, 2005). In this study, the rat PLNA was used to evaluate the immuno-sensitizing potential of 10 monoterpenes found in the essential oils of a variety of aromatic, edible and medicinal plants.
- GLP compliance:
- not specified
- Type of study:
- other: Popliteal lymph node assay (PLNA)
- Justification for non-LLNA method:
- The PLNA seems to be a reliable test for screening chemicals causing sensitization via routes of exposure other than the skin (Goebel et al., 1996; Tuschl et al., 2002).
- Species:
- other: rat
- Strain:
- other: Wistar
- Sex:
- female
- Details on test animals and environmental conditions:
- TEST ANIMALS
- Source: Oswaldo Cruz Foundation (FIOCRUZ) breeding stock
- Females (if applicable) nulliparous and non-pregnant: yes
- Age at study initiation: 7–8 week-old
- Weight at study initiation: 145 ± 23 g
- Housing: All rats were individually housed in standard plastic cages with stainless steel cover lids and wood shavings as bedding.
- Diet (e.g. ad libitum): ad libitum (Nuvitall, Nuvilab, Curitiba, PR, Brazil)
- Water (e.g. ad libitum): ad libitum (tap water)
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 23 ± 1ºC,
- Humidity (%): 70%
- Photoperiod (hrs dark / hrs light): 12-h dark/light cycle - Route:
- other: subcutaneous
- Vehicle:
- DMSO
- Concentration / amount:
- 5 mg/paw of test substance (50 µL of test substance in vehicle)
- Day(s)/duration:
- 7 days
- Adequacy of induction:
- other: It is of note that, as a rule, 5 mg/paw has been the highest dose of a test compound assayed in the rat PLNA (Vial et al., 1997; Descotes et al., 1997).
- No. of animals per dose:
- 10
- Details on study design:
- MAIN STUDY
A. INDUCTION EXPOSURE
- No. of exposures: one per animal
- Exposure period: Seven days after footpad injection, rats were killed by CO2 inhalation
- Test groups: one treated group (10 animals)
- Control group: barbital (negative control), saline (vehicle control for negative) and DMSO (vehicle control for treated group)
- Site: right footpad (treated group). The contralateral (left) hind footpad was used as the control and thus it was injected with 50 µL of vehicle alone. When the vehicles were tested, the right hind footpad was injected with 50 µL of DMSO or saline while the left hind footpad remained untreated.
OTHER:
Seven days after footpad injection, rats were killed by CO2 inhalation. The popliteal lymph nodes (PLN) were carefully removed, placed in phosphate buffer saline (PBS), freed from adherent fatty tissue and weighed. PLNs were then transferred to a glass tube where cells were extracted by agitation and gentle grinding using a micropestle and suspended in a known volume of PBS on ice. PLN cell number (cellularity) was counted using a Neubauer chamber. Results were expressed as weight
(WI) and cellularity (CI) indices. WI and CI were calculated by dividing the value (weight or cellularity) obtained for the treated (right) side PLN by that obtained for the control (left) side PLN. - Positive control substance(s):
- yes
- Remarks:
- (chlorpromazine)
- Positive control results:
- see table on "any other information on results incl. tables"
- Key result
- Reading:
- 1st reading
- Group:
- test chemical
- Dose level:
- 5 mg
- No. with + reactions:
- 2
- Total no. in group:
- 10
- Remarks on result:
- no indication of skin sensitisation
- Key result
- Reading:
- 1st reading
- Group:
- negative control
- Dose level:
- 5 mg
- No. with + reactions:
- 0
- Total no. in group:
- 8
- Remarks on result:
- no indication of skin sensitisation
- Key result
- Reading:
- 1st reading
- Group:
- positive control
- Dose level:
- 5 mg
- Remarks on result:
- positive indication of skin sensitisation
- Interpretation of results:
- other: No category (CLP Regulation EC no. 1272/2008)
- Conclusions:
- Under these test conditions, alpha-terpineol was not considered as a sensitiser.
- Executive summary:
In a popliteal lymph node assay (PLNA), a group of 10 female Wistar rats were injected subcutaneously with alpha terpineol at 5 mg/paw into the right hind footpad while the contralateral footpad was injected with the vehicle (DMSO) alone. Chlorpromazine (CPZ) and barbital were used as positive and negative controls, respectively. Weight (WI) and cellularity (CI) indices for draining PLNs were determined 7 days after treatment. Weight (WI) and cellularity (CI) indices for alpha terpineol was determined to be 1.32 and 2.00, respectively. Alpha terpineol was classified as negative because group mean values for WI and CI were lower than 2 and 5, respectively. Under these test conditions, alpha terpineol was not considered as a sensitiser.
- Endpoint:
- skin sensitisation: in vivo (non-LLNA)
- Type of information:
- experimental study
- Adequacy of study:
- weight of evidence
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- comparable to guideline study with acceptable restrictions
- Qualifier:
- equivalent or similar to guideline
- Guideline:
- OECD Guideline 406 (Skin Sensitisation)
- Version / remarks:
- modified FCA-method (Freund’s complete adjuvant) (Hausen and Angel, 1992)
- Deviations:
- yes
- Remarks:
- (no details of housing and evironmental conditions of the animals)
- GLP compliance:
- not specified
- Type of study:
- Freund's complete adjuvant test
- Justification for non-LLNA method:
- Test was performed before OECD LLNA guideline approval and based on reliable method according to OECD 406 guideline.
- Species:
- guinea pig
- Strain:
- other: Pirbright-white stem
- Sex:
- female
- Route:
- epicutaneous, open
- Vehicle:
- physiological saline
- Concentration / amount:
- 30 mg of oxidized tea tree oil (TTO) dissolved in 4 mL of FCA and emulsified with 4 mL of physiological saline.
- Day(s)/duration:
- 11 days
- Adequacy of induction:
- not specified
- No.:
- #1
- Route:
- epicutaneous, open
- Vehicle:
- other: acetone
- Concentration / amount:
- 0.05 mL of 10% alpha terpineol-solution in acetone
- Adequacy of challenge:
- not specified
- No. of animals per dose:
- 10
- Details on study design:
- MAIN STUDY
A. INDUCTION EXPOSURE
- No. of exposures: 1
- Exposure period: 11 days
- Test groups: one treated group (10 animals)
- Concentrations: 30 mg of oxidized tea tree oil (TTO) dissolved in 4 mL of FCA and emulsified with 4 mL of physiological saline.
B. CHALLENGE EXPOSURE
- No. of exposures: 1
- Test groups: one treated group (10 animals)
- Site: clipped and shaved right flank of the animals.
- Concentrations: 10% alpha terpineol-solution in acetone
- Evaluation (hr after challenge): 24, 48 and 72 hours (according to the rules of the International Contact Dermatitis Research Group (ICDRG)). - Positive control substance(s):
- no
- Key result
- Reading:
- 1st reading
- Hours after challenge:
- 24
- Group:
- test chemical
- Dose level:
- 0.05 mL of 10% alpha terpineol-solution in acetone
- No. with + reactions:
- 0
- Total no. in group:
- 10
- Remarks on result:
- no indication of skin sensitisation
- Key result
- Reading:
- 1st reading
- Hours after challenge:
- 48
- Group:
- test chemical
- Dose level:
- 0.05 mL of 10% alpha terpineol-solution in acetone
- No. with + reactions:
- 0
- Total no. in group:
- 10
- Remarks on result:
- no indication of skin sensitisation
- Key result
- Reading:
- 1st reading
- Group:
- negative control
- Remarks on result:
- other: no data
- Key result
- Reading:
- 1st reading
- Group:
- positive control
- Remarks on result:
- other: No data
- Interpretation of results:
- other: No category (CLP Regulation EC no. 1272/2008)
- Conclusions:
- Under these test conditions, alpha-terpineol was found to be a non skin sensitiser.
- Executive summary:
Experimental sensitization was performed in albino guinea pigs by a modified FCA-method (Freund’s complete adjuvant). For induction, 30 mg of oxidized tea tree oil (TTO) dissolved in 4 mL of FCA and emulsified with 4 mL of physiological saline were used on 10 female guinea pigs. Eleven days after induction, open epicutaneous challenge was performed by application of 0.05 mL of 10% alpha terpineol-solution in acetone on the clipped and shaved right flank of the animals. The reactions were read at 24 hours, 48 hours, and 72 hours. As the maximum reaction was observed in most of the animals already in the 48 hour reading, the 72 hour readings were not noted. The mean responses obtained after 24 h and 48 h were 0 and thus it is concluded that alpha terpineol is not a skin sensitizer.
In a popliteal lymph node assay (PLNA), a group of 10 female Wistar rats were injected subcutaneously with alpha terpineol at 5 mg/paw into the right hind footpad while the contralateral footpad was injected with the vehicle (DMSO) alone. Chlorpromazine (CPZ) and barbital were used as positive and negative controls, respectively. Weight (WI) and cellularity (CI) indices for draining PLNs were determined 7 days after treatment. Weight (WI) and cellularity (CI) indices for alpha terpineol was determined to be 1.32 and 2.00, respectively. Alpha terpineol was classified as negative because group mean values for WI and CI were lower than 2 and 5, respectively. Under these test conditions, alpha terpineol was not considered as a sensitiser.
- Endpoint:
- skin sensitisation: in vitro
- Data waiving:
- study scientifically not necessary / other information available
- Justification for data waiving:
- an in vitro skin sensitisation study does not need to be conducted because adequate data from an in vivo skin sensitisation study are available
- Justification for type of information:
- JUSTIFICATION FOR DATA WAIVING
In accordance with column 2 of REACH Annex VII, the study does not need to be conducted since an in vivo study on sensitisation is available. - Endpoint:
- skin sensitisation: in vivo (non-LLNA)
- Type of information:
- read-across from supporting substance (structural analogue or surrogate)
- Adequacy of study:
- weight of evidence
- Justification for type of information:
- REPORTING FORMAT FOR THE ANALOGUE APPROACH
The analogue substance alpha terpineol which shares the same functional groups with the substance L-alpha terpineol also has comparable values for the relevant molecular properties.
See attached the reporting format. - Reason / purpose for cross-reference:
- read-across source
- Key result
- Reading:
- 1st reading
- Group:
- test chemical
- Dose level:
- 5 mg
- No. with + reactions:
- 2
- Total no. in group:
- 10
- Remarks on result:
- no indication of skin sensitisation
- Remarks:
- (read-across from an analogue for which no indication of skin sensitisation was obtained with 5 mg tested)
- Key result
- Reading:
- 1st reading
- Group:
- negative control
- Dose level:
- 5 mg
- No. with + reactions:
- 0
- Total no. in group:
- 8
- Remarks on result:
- no indication of skin sensitisation
- Key result
- Reading:
- 1st reading
- Group:
- positive control
- Dose level:
- 5 mg
- Remarks on result:
- positive indication of skin sensitisation
- Interpretation of results:
- other: No category (CLP Regulation EC no. 1272/2008)
- Conclusions:
- Based on the read-across approach from the analogue alpha terpineol, laevo alpha terpineol can be considered as non sensitiser.
- Executive summary:
In a popliteal lymph node assay (PLNA), a group of 10 female Wistar rats were injected subcutaneously with alpha terpineol at 5 mg/paw into the right hind footpad while the contralateral footpad was injected with the vehicle (DMSO) alone. Chlorpromazine (CPZ) and barbital were used as positive and negative controls, respectively. Weight (WI) and cellularity (CI) indices for draining PLNs were determined 7 days after treatment. Weight (WI) and cellularity (CI) indices for alpha terpineol was determined to be 1.32 and 2.00, respectively. Alpha terpineol was classified as negative because group mean values for WI and CI were lower than 2 and 5, respectively. Under these test conditions, alpha terpineol was not considered as a sensitiser. Based on these results, the read-across approach was applied and laevo alpha terpineol can be considered as non sensitizer.
- Endpoint:
- skin sensitisation: in vivo (non-LLNA)
- Type of information:
- read-across from supporting substance (structural analogue or surrogate)
- Adequacy of study:
- weight of evidence
- Justification for type of information:
- REPORTING FORMAT FOR THE ANALOGUE APPROACH
The analogue substance alpha terpineol which shares the same functional groups with the substance L-alpha terpineol also has comparable values for the relevant molecular properties.
See attached the reporting format. - Reason / purpose for cross-reference:
- read-across source
- Key result
- Reading:
- 1st reading
- Hours after challenge:
- 24
- Group:
- test chemical
- Dose level:
- 0.05 mL of 10% alpha terpineol-solution in acetone
- No. with + reactions:
- 0
- Total no. in group:
- 10
- Remarks on result:
- no indication of skin sensitisation
- Remarks:
- (read-across from an analogue for which no indication of skin sensitisation was obtained when tested with 0.05 mL of 10% test item-solution in acetone)
- Key result
- Reading:
- 1st reading
- Hours after challenge:
- 48
- Group:
- test chemical
- Dose level:
- 0.05 mL of 10% alpha terpineol-solution in acetone
- No. with + reactions:
- 0
- Total no. in group:
- 10
- Remarks on result:
- no indication of skin sensitisation
- Remarks:
- (read-across from an analogue for which no indication of skin sensitisation was obtained when tested with 0.05 mL of 10% test item-solution in acetone)
- Key result
- Reading:
- 1st reading
- Group:
- negative control
- Remarks on result:
- other: no data
- Key result
- Reading:
- 1st reading
- Group:
- positive control
- Remarks on result:
- other: No data
- Interpretation of results:
- other: No category (CLP Regulation EC no. 1272/2008)
- Conclusions:
- Based on the read-across approach from the analogue alpha terpineol, laevo alpha terpineol can be considered as non skin sensitiser.
- Executive summary:
Experimental sensitization was performed with alpha terpineol in albino guinea pigs by a modified FCA-method (Freund’s complete adjuvant). For induction, 30 mg of oxidized tea tree oil (TTO) dissolved in 4 mL of FCA and emulsified with 4 mL of physiological saline were used on 10 female guinea pigs. Eleven days after induction, open epicutaneous challenge was performed by application of 0.05 mL of 10% alpha terpineol-solution in acetone on the clipped and shaved right flank of the animals. The reactions were read at 24 hours, 48 hours, and 72 hours. As the maximum reaction was observed in most of the animals already in the 48 hour reading, the 72 hour readings were not noted. The mean responses obtained after 24 h and 48 h were 0 and thus it is concluded that alpha terpineol is not a skin sensitizer. Based on these results, the read-across approach was applied and laevo alpha terpineol can be considered as non sensitizer.
In a popliteal lymph node assay (PLNA), a group of 10 female Wistar rats were injected subcutaneously with alpha terpineol at 5 mg/paw into the right hind footpad while the contralateral footpad was injected with the vehicle (DMSO) alone. Chlorpromazine (CPZ) and barbital were used as positive and negative controls, respectively. Weight (WI) and cellularity (CI) indices for draining PLNs were determined 7 days after treatment. Weight (WI) and cellularity (CI) indices for alpha terpineol was determined to be 1.32 and 2.00, respectively. Alpha terpineol was classified as negative because group mean values for WI and CI were lower than 2 and 5, respectively. Under these test conditions, alpha terpineol was not considered as a sensitiser.
Referenceopen allclose all
Table 1: Primary PLNA responses
Criteria |
Negative controls |
Vehicle |
Chlorpromazine |
||||
|
Terpineol |
Barbital |
DMSO |
Saline |
0.5 mg/paw |
2.5 mg/paw |
5.0 mg/paw |
N |
10 |
8 |
47 |
50 |
4 |
6 |
11 |
WI |
1.32 ± 0.71 |
1.06 ± 0.36 |
1.48 ± 0.65 |
1.12 ± 0.90 |
1.30 ± 0.35 |
2.06 ± 0.81* |
3.22 ± 1.13* |
CI |
2.00 ± 3.32 |
1.34 ± 0.92 |
2.95 ± 3.68 |
2.04 ± 2.03 |
1.26 ± 0.81 |
8.49 ± 8.91* |
8.28 ± 8.19* |
IPR, no. (%) |
2 (20) |
0 (0) |
5 (10.6) |
3 (6) |
0.0 |
50.0 |
63.6* |
* indicates that the value differs from that of the lowest dose group (0.5 mg/paw)
- Injected doses were 5 mg/paw (terpineol and barbital) or 50 µL /paw (vehicles).
- Values are means ± SD;
- Weight (WI) and Cellularity (CI) indices: values for the draining popliteal lymph node of the treated (right paw) side divided by that of the control (left paw) side.
- IPR, number (%) of rats within the group with WI ≥ 2 and CI ≥ 5.
- Terpineol was classified as negative because group mean values for WI and CI were lower than 2 and 5, respectively.
Table 1: Results of the Sensitization and Challenging Experiments
Nº of guinea pigs |
Sensitized with |
Challenged with |
Concentration |
Mean response |
|
24 h |
48 h |
||||
10 |
TTO, oxidized |
Alpha terpineol |
10% |
0 |
0 |
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed (not sensitising)
- Additional information:
In vivo skin sensitisation. Weight of evidence. Read-across approach: In a popliteal lymph node assay (PLNA), a group of 10 female Wistar rats were injected subcutaneously with alpha terpineol at 5 mg/paw into the right hind footpad while the contralateral footpad was injected with the vehicle (DMSO) alone. Chlorpromazine (CPZ) and barbital were used as positive and negative controls, respectively. Weight (WI) and cellularity (CI) indices for draining PLNs were determined 7 days after treatment. Weight (WI) and cellularity (CI) indices for alpha terpineol was determined to be 1.32 and 2.00, respectively. Alpha terpineol was classified as negative because group mean values for WI and CI were lower than 2 and 5, respectively. Under these test conditions, alpha terpineol was not considered as a sensitiser. Based on these results, the read-across approach was applied and laevo alpha terpineol can be considered as non sensitizer.
In vivo skin sensitisation. Weight of evidence. Read-across approach: Experimental sensitization was performed with alpha terpineol in albino guinea pigs by a modified FCA-method (Freund’s complete adjuvant). For induction, 30 mg of oxidized tea tree oil (TTO) dissolved in 4 mL of FCA and emulsified with 4 mL of physiological saline were used on 10 female guinea pigs. Eleven days after induction, open epicutaneous challenge was performed by application of 0.05 mL of 10% alpha terpineol-solution in acetone on the clipped and shaved right flank of the animals. The reactions were read at 24 hours, 48 hours, and 72 hours. As the maximum reaction was observed in most of the animals already in the 48 hour reading, the 72 hour readings were not noted. The mean responses obtained after 24 h and 48 h were 0 and thus it is concluded that alpha terpineol is not a skin sensitizer. Based on these results, the read-across approach was applied and laevo alpha terpineol can be considered as non sensitizer.
Respiratory sensitisation
Endpoint conclusion
- Endpoint conclusion:
- no study available
Justification for classification or non-classification
Based on the available data, the substance does not need to be classified for skin sensitization according to CLP Regulation no. 1272/2008.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
![ECHA](/o/diss-blank-theme/images/factsheets/A-REACH/factsheet/echa_logo.png)